1 1967 110 SERUM CORTISOL AND BDNF IN PATIENTS WITH MAJOR DEPRESSION-EFFECT OF YOGA. DEPRESSION IS ASSOCIATED WITH LOW SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND ELEVATED LEVELS OF SERUM CORTISOL. YOGA PRACTICES HAVE BEEN ASSOCIATED WITH ANTIDEPRESSANT EFFECTS, INCREASE IN SERUM BDNF, AND REDUCTION IN SERUM CORTISOL. THIS STUDY EXAMINED THE ASSOCIATION BETWEEN SERUM BDNF AND CORTISOL LEVELS IN DRUG-NAIVE PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS, YOGA THERAPY, AND BOTH. FIFTY-FOUR DRUG-NAIVE CONSENTING ADULT OUTPATIENTS WITH MAJOR DEPRESSION (32 MALES) RECEIVED ANTIDEPRESSANTS ONLY (N = 16), YOGA THERAPY ONLY (N = 19), OR YOGA WITH ANTIDEPRESSANTS (N = 19). SERUM BDNF ANDCORTISOL LEVELS WERE OBTAINED BEFORE AND AFTER 3 MONTHS USING A SANDWICH ELISA METHOD. ONE-WAY ANOVA, CHI-SQUARE TEST, AND PEARSON'S CORRELATION TESTS WERE USED FOR ANALYSIS. THE GROUPS WERE COMPARABLE AT BASELINE ON MOST PARAMETERS. SIGNIFICANT IMPROVEMENT IN DEPRESSION SCORES AND SERUM BDNF LEVELS, AND REDUCTION IN SERUM CORTISOL IN THE YOGA GROUPS, HAVE BEEN DESCRIBED IN PREVIOUS REPORTS. A SIGNIFICANT NEGATIVE CORRELATION WAS OBSERVED BETWEEN CHANGE IN BDNF (PRE-POST) AND CORTISOL (PRE-POST) LEVELS IN THE YOGA-ONLY GROUP (R = -0.59, P = 0.008). IN CONCLUSION, YOGA MAY FACILITATE NEUROPLASTICITY THROUGH STRESS REDUCTION IN DEPRESSED PATIENTS. FURTHER STUDIES ARE NEEDED TO CONFIRM THE FINDINGS AND DELINEATE THE PATHWAYS FOR THESE EFFECTS. 2016 2 1761 47 POSITIVE THERAPEUTIC AND NEUROTROPIC EFFECTS OF YOGA IN DEPRESSION: A COMPARATIVE STUDY. CONTEXT: THERAPEUTIC EFFECT OF YOGA IN DEPRESSION IS RECOGNIZED. NEUROPLASTIC EFFECTS OF ANTIDEPRESSANT THERAPIES ARE INFERRED BY ELEVATIONS IN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF). ROLE OF YOGA IN BOTH THESE EFFECTS HAS NOT BEEN STUDIED. MATERIALS AND METHODS: NON-SUICIDAL, CONSECUTIVE OUT-PATIENTS OF DEPRESSION WERE OFFERED YOGA EITHER ALONE OR WITH ANTIDEPRESSANTS. THE DEPRESSION SEVERITY WAS RATED ON HAMILTON DEPRESSION RATING SCALE (HDRS) BEFORE AND AT 3 MONTHS. SERUM BDNF LEVELS WERE MEASURED AT THE SAME TIME POINTS. REPEATED-MEASURES ANALYSIS OF VARIANCE WAS PERFORMED TO LOOK AT CHANGE ACROSS GROUPS WITH RESPECT TO HDRS SCORES AND BDNF LEVELS OVER 3 MONTHS OF FOLLOW-UP. RELATIONSHIP BETWEEN CHANGE IN SERUM BDNF LEVELS AND CHANGE IN HDRS SCORES WAS ASSESSED USING THE PEARSON'S CORRELATION COEFFICIENT. RESULTS: BOTH YOGA GROUPS WERE BETTER THAN DRUGS-ONLY GROUP WITH RESPECT TO REDUCTION IN HDRS SCORES. SERUM BDNF ROSE IN THE TOTAL SAMPLE IN THE 3-MONTH PERIOD. THIS WAS NOT, HOWEVER, DIFFERENT ACROSS TREATMENT GROUPS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN FALL IN HDRS AND RISE IN SERUM BDNF LEVELS IN YOGA-ONLY GROUP (R=0.702; P=0.001), BUT NOT IN THOSE RECEIVING YOGA AND ANTIDEPRESSANTS OR ANTIDEPRESSANTS-ALONE. CONCLUSIONS: NEUROPLASTIC MECHANISMS MAY BE RELATED TO THE THERAPEUTIC MECHANISMS OF YOGA IN DEPRESSION. 2013 3 1423 63 IMPROVEMENT IN NEUROCOGNITIVE FUNCTIONS AND SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR LEVELS IN PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS AND YOGA. CONTEXT AND AIMS: IMPAIRMENT IN COGNITION IS WELL-KNOWN IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. THIS STUDY EXAMINED THE EFFECT OF YOGA THERAPY WITH OR WITHOUT ANTIDEPRESSANTS AND ANTIDEPRESSANTS ALONE ON CERTAIN NEUROPSYCHOLOGICAL FUNCTIONS IN PATIENTS WITH DEPRESSION. CORRELATION BETWEEN CHANGES IN NEUROPSYCHOLOGICAL TEST PERFORMANCE AND SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVELS WAS ALSO EXPLORED. MATERIALS AND METHODS: ANTIDEPRESSANT-NAIVE/ANTIDEPRESSANT-FREE OUTPATIENTS WITH DEPRESSION RECEIVED ANTIDEPRESSANT MEDICATION ALONE (N = 23) OR YOGA THERAPY WITH (N = 26) OR WITHOUT (N = 16) ANTIDEPRESSANTS. DEPRESSION WAS ASSESSED USING THE HAMILTON DEPRESSION RATING SCALE. NEUROPSYCHOLOGICAL TESTS INCLUDED DIGIT-SPAN FORWARD AND BACKWARD, REY AUDITORY VERBAL LEARNING TEST, AND TRAIL MAKING TESTS (TMT-A AND B). THESE TESTS WERE ADMINISTERED BEFORE AND 3 MONTHS AFTER THE TREATMENT IN PATIENTS, AND ONCE IN HEALTHY COMPARISON SUBJECTS (N = 19). STATISTICAL ANALYSIS: BASELINE DIFFERENCES WERE ANALYZED USING INDEPENDENT SAMPLE T-TEST, CHI-SQUARE, AND ONE-WAY ANOVA. PAIRED T-TEST WAS USED TO ANALYZE THE CHANGE FROM BASELINE TO FOLLOW-UP. PEARSON'S CORRELATION WAS USED TO EXPLORE THE ASSOCIATION OF CHANGE BETWEEN 2 VARIABLES. RESULTS: PATIENTS HAD IMPAIRED PERFORMANCE ON MOST NEUROPSYCHOLOGICAL TESTS. AFTER 3 MONTHS, THERE WAS SIGNIFICANT IMPROVEMENT - PATIENTS' PERFORMANCE WAS COMPARABLE TO THAT OF HEALTHY CONTROLS ON MAJORITY OF THE TESTS. SIGNIFICANT INVERSE CORRELATION WAS OBSERVED BETWEEN INCREASE IN BDNF LEVELS AND IMPROVEMENT IN TMT "A" DURATION IN YOGA-ALONE GROUP (R = -0.647; P = 0.009). CONCLUSIONS: TO CONCLUDE THAT, YOGA THERAPY, ALONE OR IN COMBINATION WITH MEDICATIONS, IS ASSOCIATED WITH IMPROVED NEUROPSYCHOLOGICAL FUNCTIONS AND NEUROPLASTIC EFFECTS IN PATIENTS WITH DEPRESSION. 2018 4 555 47 CORTISOL AND ANTIDEPRESSANT EFFECTS OF YOGA. CONTEXT: HYPERCORTISOLEMIA IS WELL-KNOWN IN DEPRESSION AND YOGA HAS BEEN DEMONSTRATED EARLIER TO REDUCE THE PARAMETERS OF STRESS, INCLUDING CORTISOL LEVELS. AIM: WE AIMED TO FIND THE ROLE OF YOGA AS AN ANTIDEPRESSANT AS WELL AS ITS ACTION ON LOWERING THE SERUM CORTISOL LEVELS. SETTINGS AND DESIGN: AN OPEN-LABELED STUDY CONSISTING OF THREE GROUPS (YOGA ALONE, YOGA ALONG WITH ANTIDEPRESSANT MEDICATION AND ANTIDEPRESSANT MEDICATION ALONE) WAS CONDUCTED AT A TERTIARY CARE PSYCHIATRY HOSPITAL. METHODOLOGY: OUT-PATIENT DEPRESSIVES WHO WERE NOT SUICIDAL WERE OFFERED YOGA AS A POSSIBLE ANTIDEPRESSANT THERAPY. A VALIDATED YOGA MODULE WAS USED AS THERAPY TAUGHT OVER A MONTH AND TO BE PRACTICED AT HOME DAILY. PATIENTS WERE FREE TO CHOOSE THE DRUGS IF THEIR PSYCHIATRIST ADVISED. PATIENTS (N=54) WERE RATED ON HAMILTON DEPRESSION RATING SCALE (HDRS) WITH SERUM CORTISOL MEASUREMENTS AT BASELINE AND AFTER 3 MONTHS. IN 54 PATIENTS, ASSESSMENTS AND BLOOD TEST RESULTS WERE BOTH AVAILABLE. 19 EACH RECEIVED YOGA ALONE OR WITH DRUGS AND 16 RECEIVED DRUGS ONLY. HEALTHY COMPARISON SUBJECTS (N=18) TOO UNDERWENT MORNING CORTISOL MEASUREMENTS ONCE. RESULTS: SERUM CORTISOL WAS HIGHER IN DEPRESSIVES COMPARED WITH CONTROLS. IN THE TOTAL SAMPLE, THE CORTISOL LEVEL DROPPED SIGNIFICANTLY AT THE END OF TREATMENT. MORE PATIENTS IN THE YOGA GROUPS HAD A DROP IN CORTISOL LEVELS AS COMPARED TO DRUG-ONLY GROUP. IN THE YOGA-ONLY GROUP, THE CORTISOL DROP CORRELATED WITH THE DROP IN HDRS SCORE (ANTIDEPRESSANT EFFECT). CONCLUSION: THE FINDINGS SUPPORT THAT YOGA MAY ACT AT THE LEVEL OF THE HYPOTHALAMUS BY ITS 'ANTI-STRESS' EFFECTS (REDUCING THE CORTISOL), TO BRING ABOUT RELIEF IN DEPRESSION. 2013 5 835 34 EFFECT OF YOGA ON PAIN, BRAIN-DERIVED NEUROTROPHIC FACTOR, AND SEROTONIN IN PREMENOPAUSAL WOMEN WITH CHRONIC LOW BACK PAIN. BACKGROUND. SEROTONIN AND BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) ARE KNOWN TO BE MODULATORS OF NOCICEPTION. HOWEVER, PAIN-RELATED CONNECTION BETWEEN YOGA AND THOSE NEUROMODULATORS HAS NOT BEEN INVESTIGATED. THEREFORE, WE AIMED TO EVALUATE THE EFFECT OF YOGA ON PAIN, BDNF, AND SEROTONIN. METHODS. PREMENOPAUSAL WOMEN WITH CHRONIC LOW BACK PAIN PRACTICED YOGA THREE TIMES A WEEK FOR 12 WEEKS. AT BASELINE AND AFTER 12 WEEKS, BACK PAIN INTENSITY WAS MEASURED USING VISUAL ANALOGUE SCALE (VAS), AND SERUM BDNF AND SEROTONIN LEVELS WERE EVALUATED. ADDITIONALLY, BACK FLEXIBILITY AND LEVEL OF DEPRESSION WERE ASSESSED. RESULTS. AFTER 12-WEEK YOGA, VAS DECREASED IN THE YOGA GROUP (P < 0.001), WHEREAS IT INCREASED (P < 0.05) IN THE CONTROL GROUP. BACK FLEXIBILITY WAS IMPROVED IN THE YOGA GROUP (P < 0.01). SERUM BDNF INCREASED IN THE YOGA GROUP (P < 0.01), WHEREAS IT TENDED TO DECREASE IN THE CONTROL GROUP (P = 0.05). SERUM SEROTONIN MAINTAINED IN THE YOGA GROUP, WHILE IT REDUCED (P < 0.01) IN THE CONTROL GROUP. THE DEPRESSION LEVEL MAINTAINED IN THE YOGA GROUP, WHEREAS IT TENDED TO INCREASE IN THE CONTROL GROUP (P = 0.07). CONCLUSIONS. WE PROPOSE THAT BDNF MAY BE ONE OF THE KEY FACTORS MEDIATING BENEFICIAL EFFECTS OF YOGA ON CHRONIC LOW BACK PAIN. 2014 6 716 34 EFFECT OF INTEGRATED YOGA PRACTICES ON IMMUNE RESPONSES IN EXAMINATION STRESS - A PRELIMINARY STUDY. BACKGROUND: STRESS IS OFTEN ASSOCIATED WITH AN INCREASED OCCURRENCE OF AUTONOMIC, CARDIOVASCULAR, AND IMMUNE SYSTEM PATHOLOGY. THIS STUDY WAS DONE TO EVALUATE THE IMPACT OF STRESS ON PSYCHOLOGICAL, PHYSIOLOGICAL PARAMETERS, AND IMMUNE SYSTEM DURING MEDICAL TERM -ACADEMIC EXAMINATION AND THE EFFECT OF YOGA PRACTICES ON THE SAME. MATERIALS AND METHODS: THE STUDY WAS CARRIED OUT ON SIXTY FIRST-YEAR MBBS STUDENTS RANDOMLY ASSIGNED TO YOGA GROUP AND CONTROL GROUP (30 EACH). THE YOGA GROUP UNDERWENT INTEGRATED YOGA PRACTICES FOR 35 MINUTES DAILY IN THE PRESENCE OF TRAINED YOGA TEACHER FOR 12 WEEKS. CONTROL GROUP DID NOT UNDERGO ANY KIND OF YOGA PRACTICE OR STRESS MANAGEMENT. PHYSIOLOGICAL PARAMETERS LIKE HEART RATE, RESPIRATORY RATE, AND BLOOD PRESSURE WERE MEASURED. GLOBAL ASSESSMENT OF RECENT STRESS SCALE AND SPIELBERGERS STATE ANXIETY SCORE WERE ASSESSED AT BASELINE AND DURING THE EXAMINATION. SERUM CORTISOL LEVELS, IL-4, AND IFN-GAMMA LEVELS WERE DETERMINED BY ENZYME-LINKED IMMUNOSORBENT ASSAY TECHNIQUE. RESULT: IN THE YOGA GROUP, NO SIGNIFICANT DIFFERENCE WAS OBSERVED IN PHYSIOLOGICAL PARAMETERS DURING THE EXAMINATION STRESS, WHEREAS IN THE CONTROL GROUP, A SIGNIFICANT INCREASE WAS OBSERVED. LIKEWISE, THE INDICATORS OF PSYCHOLOGICAL STRESS SHOWED HIGHLY SIGNIFICANT DIFFERENCE IN CONTROL GROUP COMPARED WITH SIGNIFICANT DIFFERENCE IN YOGA GROUP. DURING THE EXAMINATION, THE INCREASE IN SERUM CORTICAL AND DECREASE IN SERUM IFN-GAMMA IN YOGA GROUP WAS LESS SIGNIFICANT (P<0.01) THAN IN THE CONTROL GROUP (P<0.001). BOTH THE GROUPS DEMONSTRATED AN INCREASE IN SERUM IL-4 LEVELS, THE CHANGES BEING INSIGNIFICANT FOR THE DURATION OF THE STUDY. CONCLUSION: YOGA RESISTS THE AUTONOMIC CHANGES AND IMPAIRMENT OF CELLULAR IMMUNITY SEEN IN EXAMINATION STRESS. 2011 7 748 25 EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. OBJECTIVE: THE PRESENT STUDY INVESTIGATES THE EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. DESIGN: THE PROSPECTIVE OBSERVATIONAL COHORT STUDY ENROLLED TWO STUDY GROUPS: THOSE RECEIVING TREATMENT FROM THE INTERNATIONAL SAHAJA YOGA RESEARCH AND HEALTH CENTER (MEDITATION GROUP) AND THOSE RECEIVING TREATMENT FROM THE MAHATMA GANDHI MISSION HOSPITAL (CONTROL GROUP). RESEARCHERS MEASURED QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE BEFORE AND AFTER TREATMENT. RESULTS: SIXTY-SEVEN (67) PARTICIPANTS IN THE MEDITATION GROUP AND 62 PARTICIPANTS IN THE CONTROL GROUP COMPLETED THE STUDY. THE TWO GROUPS WERE COMPARABLE IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS. AT BASELINE, THE MEDITATION GROUP HAD HIGHER QUALITY OF LIFE (P<0.001) THAN CONTROLS BUT SIMILAR ANXIETY LEVEL (P=0.74) TO CONTROLS. WITHIN-GROUP PRE- VERSUS POST-TREATMENT COMPARISONS SHOWED SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE IN THE MEDITATION GROUP (P<0.001), WHILE IN CONTROLS, QUALITY OF LIFE DETERIORATED AND THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE. THE IMPROVEMENT IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL WAS GREATER IN THE MEDITATION GROUP. THE BENEFICIAL EFFECT OF MEDITATION REMAINED SIGNIFICANT AFTER ADJUSTING FOR CONFOUNDERS. CONCLUSIONS: MEDITATION TREATMENT WAS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL. 2012 8 33 30 A 10-WEEK YOGA PRACTICE HAS NO EFFECT ON COGNITION, BUT IMPROVES BALANCE AND MOTOR LEARNING BY ATTENUATING BRAIN-DERIVED NEUROTROPHIC FACTOR LEVELS IN OLDER ADULTS. DESPITE STUDIES INVESTIGATING THE EFFECT OF YOGA ON COGNITIVE AND MOTOR FUNCTIONING IN OLDER ADULTS, THE EFFECT ON DUAL-TASK PERFORMANCE AND MOTOR LEARNING AND THE SPECIFIC MECHANISMS UNDERLYING THE POSITIVE EFFECT OF YOGA REMAIN UNCLEAR. THUS, THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECTS OF YOGA ON COGNITION, BALANCE UNDER SINGLE- AND DUAL-TASK CONDITIONS, AND MOTOR LEARNING. THE POTENTIAL ROLE OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) IN INDUCED IMPROVEMENT WAS ALSO EXPLORED. PARTICIPANTS AGED 60-79YEARS WERE RANDOMIZED TO EITHER A CONTROL GROUP (N=15) OR A YOGA GROUP (N=18) FOR A 10-WEEK PERIOD. THE YOGA GROUP RECEIVED 90-MIN DURATION YOGA CLASSES TWO TIMES PER WEEK. CHANGES IN COGNITION, BALANCE UNDER SINGLE- AND DUAL-TASK CONDITIONS, AND LEARNING FAST AND ACCURATE REACHING MOVEMENTS WERE ASSESSED. YOGA PRACTICE DECREASED (P<0.05) THE VELOCITY VECTOR OF THE CENTER OF PRESSURE UNDER SINGLE- AND DUAL-TASK CONDITIONS, WHEREAS NO CHANGES IN COGNITIVE PERFORMANCE WERE OBSERVED. ALTHOUGH REACTION AND MOVEMENT TIMES DURING LEARNING WERE DECREASED IN BOTH GROUPS (P<0.05), A FASTER REACTION TIME (P<0.05) AND SHORTER MOVEMENT TIME (P<0.05) WERE OBSERVED IN THE YOGA GROUP THAN IN THE CONTROL GROUP. SIGNIFICANT MODERATE RELATIONSHIPS (P<0.05) BETWEEN CHANGES IN BDNF LEVELS AND FUNCTIONAL IMPROVEMENTS WERE OBSERVED. THUS, 10WEEKS OF YOGA PRACTICE RESULTED IN IMPROVED BALANCE AND LEARNING IN THE SPEED-ACCURACY MOTOR TASK THAT WERE MEDIATED BY INCREASED BDNF LEVELS, BUT HAD NO IMPACT ON COGNITION IN OLDER ADULTS. 2020 9 569 18 DECREASE IN SERUM CORTISOL DURING YOGA EXERCISE IS CORRELATED WITH ALPHA WAVE ACTIVATION. WE EXAMINED CHANGES IN BRAIN WAVES AND BLOOD LEVELS OF SERUM CORTISOL DURING YOGA EXERCISE IN 7 YOGA INSTRUCTORS AND FOUND THAT ALPHA WAVES INCREASED AND SERUM CORTISOL DECREASED. THESE TWO MEASURES WERE NEGATIVELY CORRELATED (R = -.83). COMPARISON WITH A CONTROL GROUP OF NONPRACTITIONERS IS DESIRABLE. 2000 10 1542 26 KRIYA YOGA IN PATIENTS WITH DEPRESSIVE DISORDERS: A PILOT STUDY. BACKGROUND AND OBJECTIVES DESPITE THE EASY ACCEPTABILITY AND HOLISTIC NATURE OF KRIYA YOGA, THERE ARE NO STUDIES EVALUATING THE ROLE OF KRIYA YOGA INTERVENTION ON DEPRESSION. THE OBJECTIVE OF THE CURRENT STUDY WAS TO ASSESS THE FEASIBILITY AND EFFECT OF ADJUNCTIVE KRIYA YOGA ON DEPRESSION. METHODS PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO OPTED FOR KRIYA YOGA WERE RECRUITED INTO THE INTERVENTION GROUP (ADJUNCTIVE KRIYA YOGA) AND THOSE ON PSYCHOTROPIC MEDICATION ALONE WERE ENROLLED INTO THE CONTROL GROUP. THE HAMILTON DEPRESSION RATING SCALE (HDRS) MEASUREMENTS WERE RECORDED AT BASELINE, END OF 2, 4, AND 8 WEEKS. RESULTS HDRS SCORES OF THE INTERVENTION GROUP ( N = 29) WERE FOUND TO BE SIGNIFICANTLY LESSER THAN THAT OF THE CONTROL GROUP ( N = 52) BY THE END OF 2, 4, AND 8 WEEKS. THE REMISSION RATE WAS ALSO SIGNIFICANTLY GREATER IN THE INTERVENTION GROUP. CONCLUSION KRIYA YOGA INTERVENTION WAS FOUND TO BE FEASIBLE, AS WELL AS IMPROVED THE SEVERITY OF DEPRESSION. 2021 11 723 32 EFFECT OF LAUGHTER YOGA ON MENTAL SYMPTOMS AND SALIVARY CORTISOL LEVELS IN FIRST-YEAR NURSING STUDENTS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: UNIVERSITY STUDENTS ARE FACED WITH SEVERAL STRESS FACTORS AFFECTING THEIR MENTAL HEALTH. THEREFORE, THE FIRST YEAR AT UNIVERSITY IS A PERIOD THAT CALLS FOR CAREFUL ATTENTION AND RESEARCH. AIM: THE AIM OF THIS STUDY IS TO EVALUATE THE EFFECT OF LAUGHTER YOGA ON MENTAL SYMPTOMS AND CORTISOL LEVELS IN NURSING STUDENTS. METHODS: THIS STUDY IS A RANDOMIZED CONTROLLED STUDY EMPLOYING A PRE-/POST-TEST DESIGN WITH A CONTROL GROUP. A TOTAL OF 75 HEALTHY UNIVERSITY STUDENTS WERE ASSIGNED TO THE INTERVENTION GROUP AND CONTROL GROUP. THE BRIEF SYMPTOM INVENTORY WAS APPLIED TO BOTH GROUPS BEFORE SESSION 1 AND AFTER SESSION 8. SALIVA SAMPLES WERE TAKEN FROM THE STUDENTS TO MEASURE THEIR CORTISOL LEVELS BEFORE AND AFTER EACH SESSION. RESULTS: EVALUATION OF THE MEAN SCORES OBTAINED FROM THE BRIEF SYMPTOM INVENTORY BEFORE AND AFTER THE INTERVENTION SHOWED A SIGNIFICANT DECREASE IN THE SCORES BETWEEN GROUPS (P < 0.05). IN THREE OUT OF THE EIGHT SESSIONS, THERE WAS A SIGNIFICANT DECREASE IN THE INTERVENTION GROUP COMPARED WITH THE CONTROL GROUP REGARDING THE MEAN VALUES OF PRE-TEST AND POST-TEST SALIVARY CORTISOL LEVELS (P < 0.05). CONCLUSION: LAUGHTER YOGA CAN PROVIDE AN EFFECTIVE MEANS TO HELP FIRST-YEAR NURSING STUDENTS COPE WITH STRESS AND REDUCE MENTAL SYMPTOMS. 2021 12 1616 35 MINDFUL AWARENESS FOR FEMALE DENTAL STUDENTS THROUGH YOGA, MOTIVATIONAL VIDEO, AND A COMBINATION OF TWO ON STRESS REDUCTION. OBJECTIVE: ASSESSMENT OF THE POTENTIAL EFFECT OF YOGA, MOTIVATIONAL VIDEOS, AND A COMBINATION OF TWO ON STRESS REDUCTION IN FEMALE DENTAL STUDENTS. METHODS: THE CURRENT STUDY DESIGN IS A NONRANDOMIZED TRIAL CARRIED OUT AMONG FEMALE DENTAL STUDENTS (N = 120). THE SELECTED SUBJECTS WERE ALLOCATED INTO THREE GROUPS, NAMELY, GROUP A: YOGA GROUP ASSIGNED UNDER A PROFESSIONAL YOGA INSTRUCTOR, GROUP B: MOTIVATIONAL VIDEO GROUP, AND GROUP C: A COMBINATION OF TWO (A AND B) INVOLVING YOGA SESSIONS AND MOTIVATIONAL VIDEOS; FOLLOWING WHICH FORMATIVE EXAMINATIONS WERE CARRIED OUT AT 6 WEEKS WHICH WERE REFERRED TO AS STRESSOR 1 AND THOSE CARRIED OUT AT 12 WEEKS WERE REFERRED TO AS STRESSOR 2. USING SPIELBERGER'S STATE-TRAIT ANXIETY INVENTORY FOR ADULTS (STAI-A) RECORDINGS WERE MEASURED AT BASELINE, STRESSOR 1, AND STRESSOR 2. RESULTS: THERE WAS A SIGNIFICANT DECREASE IN TRAIT ANXIETY SCORES AT BOTH STRESSORS IN ALL THE GROUPS WITH A SIGNIFICANT REDUCTION IN DEPRESSION SCORE FROM STRESSOR 1 TO 2 IN GROUP 1 AND GROUP 3 SUBJECTS. THE SIGNIFICANT DECREASE OCCURRED IN STAI-A SCORES IN GROUP 1 AND GROUP 3 SUBJECTS AT BOTH STRESSORS (P < 0.001) WITH NO CHANGE OBSERVED IN GROUP 2 SUBJECTS. CONCLUSION: THE PRESENT STUDY IS ONE OF A KIND AND POSITIVELY CORRELATES YOGA AND MOTIVATIONAL VIDEOS WITH STRESS REDUCTION. BOTH OF THESE INTERVENTIONS PROVED TO BE BENEFICIARY FOR PHYSICAL AS WELL AS MENTAL HEALTH OF STUDY SUBJECTS. 2020 13 244 31 A YOGA AND COMPASSION MEDITATION PROGRAM REDUCES STRESS IN FAMILIAL CAREGIVERS OF ALZHEIMER'S DISEASE PATIENTS. FAMILIAL CAREGIVERS OF PATIENTS WITH ALZHEIMER'S DISEASE EXHIBIT REDUCED QUALITY OF LIFE AND INCREASED STRESS LEVELS. THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECTS OF AN 8-WEEK YOGA AND COMPASSION MEDITATION PROGRAM ON THE PERCEIVED STRESS, ANXIETY, DEPRESSION, AND SALIVARY CORTISOL LEVELS IN FAMILIAL CAREGIVERS. A TOTAL OF 46 VOLUNTEERS WERE RANDOMLY ASSIGNED TO PARTICIPATE IN A STRESS-REDUCTION PROGRAM FOR A 2-MONTH PERIOD (YOGA AND COMPASSION MEDITATION PROGRAM-YCMP GROUP) (N = 25) OR AN UNTREATED GROUP FOR THE SAME PERIOD OF TIME (CONTROL GROUP) (N = 21). THE LEVELS OF STRESS, ANXIETY, DEPRESSION, AND MORNING SALIVARY CORTISOL OF THE PARTICIPANTS WERE MEASURED BEFORE AND AFTER INTERVENTION. THE GROUPS WERE INITIALLY HOMOGENEOUS; HOWEVER, AFTER INTERVENTION, THE GROUPS DIVERGED SIGNIFICANTLY. THE YCMP GROUP EXHIBITED A REDUCTION OF THE STRESS (P < 0.05), ANXIETY (P < 0.000001), AND DEPRESSION (P < 0.00001) LEVELS, AS WELL AS A REDUCTION IN THE CONCENTRATION OF SALIVARY CORTISOL (P < 0.05). OUR STUDY SUGGESTS THAT AN 8-WEEK YOGA AND COMPASSION MEDITATION PROGRAM MAY OFFER AN EFFECTIVE INTERVENTION FOR REDUCING PERCEIVED STRESS, ANXIETY, DEPRESSION, AND SALIVARY CORTISOL IN FAMILIAL CAREGIVERS. 2013 14 330 30 APPLICATION OF AN INTEGRATIVE YOGA THERAPY PROGRAMME IN CASES OF ESSENTIAL ARTERIAL HYPERTENSION IN PUBLIC HEALTHCARE. OBJECTIVE: TO EXAMINE THE EFFICACY OF AN INTEGRATIVE YOGA PROGRAMME AS ADJUVANT TREATMENT OF ESSENTIAL ARTERIAL HYPERTENSION. METHODS: AN INTEGRATIVE YOGA PROGRAMME WAS CONDUCTED DURING THREE MONTHS IN 26 SESSIONS WITH A GROUP OF TEN ESSENTIAL ARTERIAL HYPERTENSION PATIENTS AT A PUBLIC HEALTH CENTRE. THE SAME NUMBER OF PATIENTS ACTED AS THE CONTROL GROUP WITHOUT TREATMENT. THE PATIENTS WERE RANDOMLY SELECTED AND ASSIGNED TO THE GROUPS. ALL PATIENTS FILLED IN THE POSITIVE AND NEGATIVE AFFECT SCHEDULE (PANAS), THE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) AND THE SMITH RELAXATION STATES INVENTORY 3 (SRSI3) BEFORE AND AFTER THE TREATMENT. RESULTS: A STATISTICALLY SIGNIFICANT REDUCTION OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, NEGATIVE AFFECT, SYMPTOMS OF ANXIETY AND DEGREE OF STRESS COULD BE OBSERVED IN THE STUDY GROUP. CONCLUSIONS: THESE POSITIVE AND PROMISING RESULTS CONFIRM THE EFFECTIVENESS OF THESE TECHNIQUES IN THE TREATMENT OF ESSENTIAL ARTERIAL HYPERTENSION AND SUGGEST POSSIBLE FURTHER INVESTIGATIONS. 2014 15 1826 26 PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF LAUGHTER YOGA SESSIONS IN JAPAN: A PILOT STUDY. THE PURPOSE OF THIS PILOT STUDY WAS TO EXAMINE AND EVALUATE THE PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF MULTIPLE SESSIONS OF LAUGHTER YOGA ON COMMUNITY MEMBERS. PARTICIPANTS TOOK PART IN A 45 MIN LAUGHTER YOGA SESSION ONCE PER MONTH FOR 6 MONTHS. BEFORE AND AFTER ALL SESSIONS, PARTICIPANTS COMPLETED THE PROFILE OF MOOD STATES-BRIEF JAPANESE VERSION (J-POMS-B) QUESTIONNAIRE TO ASSESS THEIR MOOD, AND HAD BLOOD DRAWN FOR THE MEASUREMENT OF STRESS INDICATORS AND IMMUNE FUNCTION. SERIAL CHANGES IN J-POMS-B SCORES WERE TESTED BY THREE WAY ANALYSIS OF VARIANCE, AND CHANGES IN LABORATORY RESULTS PER SESSION WERE EVALUATED WITH A PAIRED T-TEST. THE RESULTS SHOWED THAT REPEATED SESSIONS OF LAUGHTER YOGA HAD PSYCHOLOGICALLY BENEFICIAL EFFECTS, ESPECIALLY ON THE ASPECTS OF TENSION-ANXIETY, AND VIGOR. ADRENOCORTICOTROPIC HORMONE AND CORTISOL VALUES RELATED TO THE PARTICIPANTS' STRESS LEVELS WERE SIGNIFICANTLY DECREASED AFTER THE FOURTH LAUGHTER YOGA SESSION. THESE RESULTS INDICATED THAT MULTIPLE LAUGHTER YOGA SESSIONS APPEARED TO BE EFFECTIVE IN IMPROVING THE PSYCHOLOGICAL AND PHYSIOLOGICAL STATUS OF HEALTHY ADULTS. 2018 16 1402 39 IMPACT OF YOGA ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION - A CONTROLLED TRIAL IN PRIMARY CARE, MATCHED FOR SYSTOLIC BLOOD PRESSURE. BACKGROUND: MEDICAL TREATMENT OF HYPERTENSION IS NOT ALWAYS SUFFICIENT TO ACHIEVE BLOOD PRESSURE CONTROL. DESPITE THIS, PREVIOUS STUDIES ON SUPPLEMENTARY THERAPIES, SUCH AS YOGA, ARE RELATIVELY FEW. WE INVESTIGATED THE EFFECTS OF TWO YOGA INTERVENTIONS ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS IN PRIMARY HEALTH CARE DIAGNOSED WITH HYPERTENSION. METHODS: ADULT PATIENTS (AGE 20-80 YEARS) WITH DIAGNOSED HYPERTENSION WERE IDENTIFIED BY AN ELECTRONIC CHART SEARCH AT A PRIMARY HEALTH CARE CENTER IN SOUTHERN SWEDEN. IN TOTAL, 83 SUBJECTS WITH BLOOD PRESSURE VALUES OF 120-179/